Cochlear Limited (COH.AX)
AUD 291.11
(-1.13%)
AUD 291.11
(-1.13%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -269.9 Million AUD | 23.69% |
| 2023 | -353.7 Million AUD | 5.78% |
| 2022 | -375.4 Million AUD | -8.72% |
| 2021 | -345.3 Million AUD | -347.53% |
| 2020 | 139.5 Million AUD | 35.44% |
| 2019 | 103 Million AUD | 19.49% |
| 2018 | 86.2 Million AUD | -33.4% |
| 2017 | 129.42 Million AUD | 9.85% |
| 2016 | 117.82 Million AUD | -16.14% |
| 2015 | 140.5 Million AUD | -22.5% |
| 2014 | 181.28 Million AUD | 53.92% |
| 2013 | 117.78 Million AUD | 4285.5% |
| 2012 | -2.81 Million AUD | 70.01% |
| 2011 | -9.38 Million AUD | -108.24% |
| 2010 | 113.93 Million AUD | 4.95% |
| 2009 | 108.56 Million AUD | -18.55% |
| 2008 | 133.29 Million AUD | 15.4% |
| 2007 | 115.5 Million AUD | 6.0% |
| 2006 | 108.96 Million AUD | 11.86% |
| 2005 | 97.41 Million AUD | 294.52% |
| 2004 | -50.07 Million AUD | -73.37% |
| 2003 | -28.88 Million AUD | -310.65% |
| 2002 | 13.71 Million AUD | 164.27% |
| 2001 | -21.33 Million AUD | -2.6% |
| 2000 | -20.79 Million AUD | 31.53% |
| 1999 | -30.36 Million AUD | -83.94% |
| 1998 | -16.51 Million AUD | -55.14% |
| 1997 | -10.64 Million AUD | 12.54% |
| 1996 | -12.16 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -278.5 Million AUD | 0.0% |
| 2024 FY | -269.9 Million AUD | 23.69% |
| 2024 Q4 | -269.9 Million AUD | 0.0% |
| 2023 Q4 | -353.7 Million AUD | 0.0% |
| 2023 FY | -353.7 Million AUD | 5.78% |
| 2023 Q2 | -271.3 Million AUD | 0.0% |
| 2022 FY | -375.4 Million AUD | -8.72% |
| 2022 Q4 | -375.4 Million AUD | 0.0% |
| 2022 Q2 | -287 Million AUD | 0.0% |
| 2021 Q4 | -345.3 Million AUD | 0.0% |
| 2021 FY | -345.3 Million AUD | -347.53% |
| 2021 Q2 | -254.6 Million AUD | 0.0% |
| 2020 FY | 139.5 Million AUD | 35.44% |
| 2020 Q2 | 333 Million AUD | 0.0% |
| 2020 Q4 | 139.5 Million AUD | 0.0% |
| 2019 FY | 103 Million AUD | 19.49% |
| 2019 Q2 | 72.7 Million AUD | 0.0% |
| 2019 Q4 | 103 Million AUD | 0.0% |
| 2018 Q4 | 86.2 Million AUD | 0.0% |
| 2018 FY | 86.2 Million AUD | -33.4% |
| 2018 Q2 | 137.1 Million AUD | 0.0% |
| 2017 Q2 | 93.52 Million AUD | 0.0% |
| 2017 FY | 129.42 Million AUD | 9.85% |
| 2017 Q4 | 129.42 Million AUD | 0.0% |
| 2016 FY | 117.82 Million AUD | -16.14% |
| 2016 Q4 | 117.82 Million AUD | 0.0% |
| 2016 Q2 | 132.86 Million AUD | 0.0% |
| 2015 Q4 | 140.5 Million AUD | 0.0% |
| 2015 Q2 | 171.6 Million AUD | 0.0% |
| 2015 FY | 140.5 Million AUD | -22.5% |
| 2014 Q4 | 181.28 Million AUD | 0.0% |
| 2014 FY | 181.28 Million AUD | 53.92% |
| 2014 Q2 | 166.32 Million AUD | 0.0% |
| 2013 Q4 | 117.78 Million AUD | 323.54% |
| 2013 FY | 117.78 Million AUD | 4285.5% |
| 2013 Q2 | -69.79 Million AUD | 0.0% |
| 2013 Q1 | -69.79 Million AUD | -2380.31% |
| 2013 Q3 | -52.68 Million AUD | 24.51% |
| 2012 FY | -2.81 Million AUD | 70.01% |
| 2012 Q4 | -2.81 Million AUD | 0.0% |
| 2011 FY | -9.38 Million AUD | -108.24% |
| 2011 Q4 | -9.38 Million AUD | 0.0% |
| 2010 Q4 | 113.93 Million AUD | 0.0% |
| 2010 FY | 113.93 Million AUD | 4.95% |
| 2009 FY | 108.56 Million AUD | -18.55% |
| 2009 Q4 | 108.56 Million AUD | 0.0% |
| 2008 FY | 133.29 Million AUD | 15.4% |
| 2008 Q4 | 133.29 Million AUD | 0.0% |
| 2007 Q4 | 115.5 Million AUD | 0.0% |
| 2007 FY | 115.5 Million AUD | 6.0% |
| 2006 Q4 | 108.96 Million AUD | 0.0% |
| 2006 FY | 108.96 Million AUD | 11.86% |
| 2005 FY | 97.41 Million AUD | 294.52% |
| 2005 Q4 | 97.41 Million AUD | 0.0% |
| 2004 FY | -50.07 Million AUD | -73.37% |
| 2004 Q4 | -50.07 Million AUD | 0.0% |
| 2003 Q4 | -28.88 Million AUD | 0.0% |
| 2003 FY | -28.88 Million AUD | -310.65% |
| 2002 FY | 13.71 Million AUD | 164.27% |
| 2002 Q4 | 13.71 Million AUD | 0.0% |
| 2001 FY | -21.33 Million AUD | -2.6% |
| 2001 Q4 | -21.33 Million AUD | 0.0% |
| 2000 Q4 | -20.79 Million AUD | 0.0% |
| 2000 FY | -20.79 Million AUD | 31.53% |
| 1999 FY | -30.36 Million AUD | -83.94% |
| 1999 Q4 | -30.36 Million AUD | 0.0% |
| 1998 FY | -16.51 Million AUD | -55.14% |
| 1998 Q4 | -16.51 Million AUD | 0.0% |
| 1997 Q4 | -10.64 Million AUD | 0.0% |
| 1997 FY | -10.64 Million AUD | 12.54% |
| 1996 FY | -12.16 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | -959.032% |
| Adherium Limited | -6.1 Million AUD | -4321.449% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -7102.813% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -7390.314% |
| Anteris Technologies Ltd | -28.49 Million AUD | -847.05% |
| Control Bionics Limited | -19.02 Thousand AUD | -1418783.398% |
| CardieX Limited | 2.74 Million AUD | 9927.69% |
| Compumedics Limited | 5.08 Million AUD | 5405.681% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 38734.854% |
| Cyclopharm Limited | -7.49 Million AUD | -3499.086% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | -1618.975% |
| Nova Eye Medical Limited | -2.8 Million AUD | -9532.405% |
| HeraMED Limited | -799.34 Thousand AUD | -33665.018% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 1963.58% |
| ImpediMed Limited | -23.48 Million AUD | -1049.048% |
| InhaleRx Limited | -155.54 Thousand AUD | -173420.033% |
| LBT Innovations Limited | -604 Thousand AUD | -44585.43% |
| Micro-X Limited | 826.99 Thousand AUD | 32736.073% |
| Neurotech International Limited | -2.11 Million AUD | -12688.56% |
| OncoSil Medical Limited | -4.43 Million AUD | -5991.552% |
| PolyNovo Limited | -30.52 Million AUD | -784.135% |
| Respiri Limited | 413.68 Thousand AUD | 65342.247% |
| SomnoMed Limited | -15.16 Million AUD | -1680.011% |
| Universal Biosensors, Inc. | -5.3 Million AUD | -4988.665% |
| Uscom Limited | -1.53 Million AUD | -17533.228% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -6510.416% |